Effects of adjunctive brexpiprazole on calmness and life engagement in major depressive disorder: post hoc analysis of patient-reported outcomes from clinical trial exit interviews

BACKGROUND: Though often overlooked, calming patients and increasing their life engagement are key factors in the treatment of major depressive disorder (MDD). This study aimed to test the hypothesis that adjunctive brexpiprazole increases calmness and life engagement among patients with MDD, based...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Catherine, Meehan, Stine R., Brown, T. Michelle, Gupta, Catherine, Mørup, Michael F., Thase, Michael E., McIntyre, Roger S., Ismail, Zahinoor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665966/
https://www.ncbi.nlm.nih.gov/pubmed/34894307
http://dx.doi.org/10.1186/s41687-021-00380-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665966/
https://www.ncbi.nlm.nih.gov/pubmed/34894307
http://dx.doi.org/10.1186/s41687-021-00380-4

Ejemplares similares